LeMaitre Vascular (LMAT:NASDAQ) Investor Relations Material

Overview

LeMaitre Vascular, Inc., a global medical device company, is revolutionizing the treatment of peripheral vascular disease with its innovative range of implants and devices. The company's offerings include restoreflow allografts, angioscope, embolectomy catheters, thrombectomy catheters, occlusion catheters, perfusion catheters, and thrombectomy catheters featuring a silicone balloon. Additionally, LeMaitre Vascular provides artegraft biologic graft, carotid shunts, radiopaque tape, valvulotomes, vascular grafts, vascular and cardiac patches, and closure systems. The company markets these products through a direct sales force and various distributors. Founded in 1983 as Vascutech, Inc., the company has its headquarters in Burlington, Massachusetts.

Frequently Asked Questions

What is LeMaitre Vascular's ticker?

LeMaitre Vascular's ticker is LMAT

What exchange is LeMaitre Vascular traded on?

The company's shares trade on the NASDAQ stock exchange

Where are LeMaitre Vascular's headquarters?

They are based in Burlington, Massachusetts

How many employees does LeMaitre Vascular have?

There are 201-500 employees working at LeMaitre Vascular

What is LeMaitre Vascular's website?

It is lemaitre.com

What type of sector is LeMaitre Vascular?

LeMaitre Vascular is in the Healthcare sector

What type of industry is LeMaitre Vascular?

LeMaitre Vascular is in the Medical Instruments & Supplies industry

Who are LeMaitre Vascular's peers and competitors?

The following five companies are LeMaitre Vascular's industry peers:

- Pro-Dex

- Dexcom

- West Pharmaceutical Services

- NuVasive

- Inspecs Group PLC